Introduction
activates c-Raf-1. Direct binding of the two purified proteins has been shown to be insufficient to activate c-Raf-1 is a member of a protein kinase family including c-Raf-1 (Traverse et al., 1993; Zhang et al., 1993) . A-Raf and B-Raf, which play a crucial role in the However, co-expression of the two proteins in vivo causes transmission of signals initiated at the plasma membrane the recruitment of c-Raf-1 to the plasma membrane where by a variety of signals, including growth factors, oncogenes activation takes place (Traverse et al., 1993; Leevers et al., and differentiating agents (reviewed in Avruch et al., 1994; Stokoe et al., 1994) . Indeed, all of the c-Raf-1 1994; Rapp et al., 1994) . Raf proteins share three conactivity isolated from such cells is associated with the served regions, CR1, CR2 and CR3, the latter of which plasma membrane (Stokoe et al., 1994;  Wartmann and is the kinase domain itself. The N-terminus of c-Raf-1, Davis, 1994) . Consistent with the idea that a component which includes the CR1 domain, was shown to bind in the plasma membrane is responsible for the activation specifically and with high affinity to the GTP-bound form of c-Raf-1, targeting of c-Raf-1 to cell membranes by of Ras in vitro (Aelst et al., 1993; Vojtek et al., 1993;  addition of Ras prenylation sequences, is sufficient to Warne et al., 1993; Zhang et al., 1993) , and Ras/Raf activate c-Raf-1 independently of Ras ; complexes have been isolated from stimulated cells Stokoe et al., 1994) . One possibility for the activation event (Finney et al., 1993; Hallberg et al., 1994) . Activated Raf proteins are able to phosphorylate and activate the dual could be through phosphorylation. In addition to the two tyrosine residues mentioned above, c-Raf-1 is also ( Figure 1B ). Similar activation was seen whether c-Raf-1 was assayed using direct phosphorylation of 'kinase-dead' phosphorylated on a multitude of serine and threonine residues in vivo, including Ser43, Ser259, Ser499 and MEK, or when c-Raf-1 activity was assayed by its ability to activate recombinant MEK (our unpublished data). As Ser621 (Kolch et al., 1993; Morrison et al., 1993) , although only phosphorylation on Ser259 has been shown to the latter assay is more specific for c-Raf-1 activity it was used routinely in subsequent experiments. Comparable increase upon c-Raf-1 activation in vivo . This residue has subsequently been shown to be with the c-Raf-1 activity seen upon co-transfection with H-RasG12V ( Figure 1A ), the activity of c-Raf-1 activated critical for the interaction of c-Raf-1 with 14-3-3 proteins (Michaud et al., 1995; Muslin et al., 1996) , although in vitro was entirely associated with the H-RasG12V membranes, despite the majority of the c-Raf-1 protein mutation to alanine does not inhibit c-Raf-1 activity, and may actually increase c-Raf-1 activity marginally remaining unbound. The specificity of the interaction was demonstrated by preincubation of the H-RasG12V Michaud et al., 1995) . An increase in B-Raf phosphorylation is also seen following prolonged membranes with a glutathione (GST) fusion protein containing the Ras binding domain (RBD) of c-Raf-1, or by stimulation with growth factors, and is accompanied by an upward mobility shift, but the time course of this is preincubation with the Ras monoclonal antibody Y13-259, which competes with c-Raf-1 for binding to the delayed with respect to B-Raf activation (Traverse and Cohen, 1994) . Nevertheless, it has been recently suggested effector domain of Ras. Both proteins abolished the binding and activation of c-Raf-1 by H-RasG12V memthat activation of c-Raf-1 by Ras does occur as a result of phosphorylation, both on tyrosine and serine/threonine branes ( Figure 2A ). In contrast, pre-incubation of the H-RasG12V membranes with the Ras monoclonal antiresidues. Addition of either serine/threonine-specific or tyrosine-specific phosphatases to c-Raf-1 isolated from body Y13-238 did not affect either the binding or activation of c-Raf-1. Two mutations in the N-terminus of c-Raf-1 c-Raf-1 and Ras-infected Sf9 cells, was shown to decrease the activity of c-Raf-1, and the activity of c-Raf-1 isolated have previously been shown to reduce the binding to Ras, namely R89L (Fabian et al., 1994) and C168S (Zhang from Ras-transformed NIH3T3 cell membranes was decreased upon incubation with a tyrosine-specific phoset al., 1993; Hu et al., 1995) . As shown in Figure  2B , either of these mutations abolished the binding and phatase (Dent et al., 1995a; Jelinek et al., 1996) .
Here, we establish an in vitro system to study the activation of c-Raf-1 by H-RasG12V membranes in this system. activation of c-Raf-1 by Ras. This approach gives a clearer interpretation than studying c-Raf-1 activated in vivo, as additional modifications may occur following several days Ras is the only protein in the membranes required for Raf activation or weeks in culture, for example via autocrine loops. These secondary modifications may exert additional levels The system described above utilized crude cytosol and membrane components. However, in agreement with other of control on c-Raf-1 activity, while having little to do with the initial activating event. Our results suggest studies , addition of purified recombinant GTP-loaded K-Ras was unable to activate purified that the activation of c-Raf-1 by Ras is not due to phosphorylation, and that Ras is the only component in recombinant c-Raf-1 (our unpublished data). Therefore experiments were performed to determine which additional the plasma membrane required for this activation. The data obtained are consistent with a critical role of tyrosine components were required for activation. Purification of c-Raf-1 away from additional cytosolic components by a phosphorylation in the activation of c-Raf-1 by Src; however, in the system we have developed, serine/threovariety of biochemical techniques abolished the ability to be activated by H-RasG12V membranes. Also, addition nine phosphorylation of c-Raf-1 seems to be more important in the down-regulation, rather than up-regulation, of of cytosol to recombinant c-Raf-1 did not support activation by H-RasG12V membranes (our unpublished data). its activity.
However, addition of purified, prenylated recombinant K-Ras loaded with GTPγS to control membranes, sup-
Results
ported the binding and activation of c-Raf-1 in cytosol to the same extent as H-RasG12V membranes ( Figure 3A , Activation of Raf in vitro by Ras membranes As shown previously Stokoe et al., lane 3) . Denaturation of integral membrane proteins by heating, protease treatment, or by addition of chloroform/ 1994), transient transfection of epitope-(myc-) tagged c-Raf-1 into COS1 cells resulted in a predominantly methanol abolished the ability of H-RasG12V membranes to activate c-Raf-1 ( Figure 3A , lanes 4 and 5). However, cytosolic localization of c-Raf-1, which possessed low levels of activity, whereas co-transfection with HRasG12V the same treatment of control membranes, followed by addition of K-Ras.GTPγS, resulted in binding and activaresulted in a partial translocation of c-Raf-1 to the membrane, where c-Raf-1 was activated ( Figure 1A ). To tion of c-Raf-1 to the same extent as intact H-RasG12V membranes ( Figure 3A , lanes 6-8). These experiments determine whether this activation can be reproduced in vitro, the cytosolic fraction of COS1 cells transiently excluded the possibility that an integral membrane protein was required for activation. To determine the requirements expressing c-Raf-1 was mixed with the membrane fraction from COS1 cells transiently expressing H-RasG12V. As for membrane lipids, K-Ras.GTPγS was added to a reconstituted mixture of phospholipids designed to mimic the shown in Figure 1B , membranes from H-RasG12V transfected cells bound a significantly greater proportion of constitution of the plasma membrane. Figure 3B shows that this also resulted in the activation of c-Raf-1, whereas c-Raf-1 than control membranes (lane 4 versus lane 2). Significantly, the c-Raf-1 associated with the H-RasG12V addition of phospholipids in the absence of K-Ras did not activate c-Raf-1. Finally, lipids were omitted entirely from membranes, but not the control membranes, was activated the incubation and purified K-Ras.GTPγS added directly to co-transfection with H-RasG12V ( Figure 4A , lane 4). In contrast, no c-Raf-1 protein was immunoprecipitated by c-Raf-1 cytosol, which also resulted in c-Raf-1 activation. Purified K-Ras loaded with GDPβS had a reduced ability the Ras antibody when H-RasG12V was omitted from the transfection ( Figure 4A , lane 3), or when c-Raf-1 cytosol to activate c-Raf-1, whereas unprenylated K-Ras.GTPγS was essentially unable to activate c-Raf-1 ( Figure 3B ).
was mixed with control membranes ( Figure 4B , lane 3), or when the Ras antibody Y13-259 was used to immunoprecipitate H-RasG12V ( Figure 4A , lane 5). The Ras forms a tight complex with Raf in vitro and in vivo complex can also be detected by immunoprecipitation through c-Raf-1 and blotting for H-RasG12V, following Although Ras/Raf complexes have been isolated from growth factor-stimulated cells (Finney et al., 1993;  activation of c-Raf-1 by H-RasG12V both in vitro, and in vivo ( Figure 4C ). It can be estimated from these Hallberg et al., 1994) , it has been previously suggested that once c-Raf-1 has been activated by Ras at the plasma experiments that~10-30% of the c-Raf-1 associated with the membranes is in a complex with H-RasG12V, but that membrane, the active c-Raf-1 dissociates from Ras but still remains anchored to the plasma membrane (Leevers this comprises 60-90% of the c-Raf-1 activity. et al., 1994) . As no membrane components were required for c-Raf-1 activation in the experiments described above Activation of Raf by Ras is independent of phosphorylation ( Figure 3) , it was important to determine whether c-Raf-1 also dissociated from Ras following activation under these
The activation of c-Raf-1 by H-RasG12V seen in Figures  1-4 was performed in the presence of EDTA, which conditions. Figure 4B However, since c-Raf-1 forms a tight complex with H-RasG12V following addition of the two proteins ( Figure  4 ), there remains the possibility that, although the initial [ 32 P]phosphate, although some were non-specific, as shown by a similar pattern of bands occurring in a c-Raf-1 binding step is phosphorylation-independent, activation of c-Raf-1 only occurs during the assay of c-Raf-1 activity, K375A immune complex ( Figure 6A , lanes 1 and 3). However, an~80 kDa protein present in both the c-Raf-1 when ATP is added to the complex. To detect phosphorylation occurring at this stage, c-Raf-1 was immunoprecipitand H-RasG12V immune complexes was not present when c-Raf-1 K375A S100 was mixed with H-RasG12V ated following binding to H-RasG12V membranes, then incubated in the presence of Mg and [γ-32 P]ATP. In the membranes, immunoprecipitated, and incubated with Mg-[γ-32 P]ATP. Although the phosphorylated protein in lanes c-Raf-1 immune complex, a number of bands incorporated 1 and 2 migrated at a slightly lower mobility than the 74 kDa c-Raf-1 protein visualized by immunoblotting ( Figure 6B ), its identity was confirmed as c-Raf-1, and not an endogenous cellular protein present in the c-Raf-1 immune complex, by performing the same set of experiments using RafCAAX. The phosphorylated protein now migrated higher than 80 kDa due to the presence of the additional CAAX motifs (our unpublished data). Phosphorylation of RafCAAX under these conditions occurred to the same extent from c-Raf-1 activated in vitro compared with c-Raf-1 activated in vivo, and occurred on the same set of sites as judged by two-dimensional phosphopeptide mapping (our unpublished data). Phosphoamino acid analysis of the 32 P-phosphorylated polypeptide showed the presence of phosphoserine and phosphothreonine, but no detectable phosphotyrosine ( Figure 6C ).
To examine further the possibility of tyrosine phosphorylation on c-Raf-1 following activation by H-Ras-G12V, immunoblotting with tyrosine-specific monoclonal antibodies was performed. Figure 7 shows that c-Raf-1 (lane 6). To demonstrate the effectiveness of the phosphotyrosine antibodies, c-Raf-1 isolated from COS1 cells coexpressing Y527FSrc, or H-RasG12V and Y527FSrc, was of c-Raf-1 with Y527FSrc did not significantly stimulate the activity of c-Raf-1 ( Figure 7C , lane 3), whereas also examined. In Figure 7 , lanes 3 and 4 show that coexpression of Y527FSrc caused tyrosine phosphorylation co-expression of c-Raf-1 with both H-RasG12V and Y527FSrc caused a 4-to 8-fold enhancement of c-Raf-1 of c-Raf-1, which was dramatically enhanced by coexpression with H-RasG12V. In these cells, co-expression activity compared with that seen with H-RasG12V alone ( Figure 7C , lane 4), in agreement with previous studies regenerating system to the incubation. Figure 9C shows that addition of an ATP-regenerating system to c-Raf-1 (Williams et al., 1992; Fabian et al., 1993; Marais et al., 1995) .
cytosol and H-RasG12V membranes caused a dramatic inhibition in the activation of c-Raf-1, which was accomTo further test the possibility of H-RasG12V causing activation of c-Raf-1 through tyrosine phosphorylation, panied by an upward mobility shift of the c-Raf-1 which remained unbound to the H-RasG12V membranes (Figure the effect of mutations at the previously identified sites of tyrosine phosphorylation were examined. As previously 9B). This mobility shift was due to phosphorylation as incubation with a serine/threonine-specific phosphatase reported, mutation of tyrosine residues 340 and 341 to aspartate resulted in a c-Raf-1 polypeptide that exhibited reversed the mobility shift (our unpublished data). The reduction in c-Raf-1 activation by H-RasG12V membranes constitutive activity which, in contrast to c-Raf-1 activated by H-RasG12V, was entirely cytosolic (Figure 8 ). Howin the presence of the ATP-regenerating system was also accompanied by a reduction in the amount of c-Raf-1 ever, this mutant still retained the ability to be substantially activated by H-RasG12V, and the additional activity binding to the H-RasG12V membranes ( Figure 9B , compare lane 4 with lane 3). Membranes from COS1 cells bestowed on c-Raf-1 by H-RasG12V was entirely at the plasma membrane (Figure 8 ). In contrast, this mutant was expressing Y527FSrc alone were unable to activate c-Raf-1 either in the presence or absence of ATP (our unpublished unable to be further activated by H-RasG12V and Src, compared with the activation by H-RasG12V alone ( Figure  data) . However, although membranes from COS1 cells expressing both H-RasG12V and Y527FSrc activated 8). This further demonstrates that H-RasG12V is causing activation of c-Raf-1 through mechanisms other than c-Raf-1 to a similar degree in the presence of EDTA, when an ATP-regenerating system was added to the tyrosine phosphorylation on residues 340 and 341, and Src is most likely exerting its effect through phosphorylation of incubation, there was a 2-fold increase in c-Raf-1 activation by these membranes relative to activation by these residues.
H-RasG12V membranes ( Figure 9C ), which was associated with an increase in tyrosine phosphorylation (Figure 
Activation of Raf by Ras and Src in vitro
To investigate whether the enhanced c-Raf-1 activation 9A, lanes 6). This suggests that, in the presence of ATP, there is an inhibitory event which occurs to c-Raf-1 occurring in COS1 cells expressing c-Raf-1, H-RasG12V and Y527FSrc, relative to cells expressing c-Raf-1 and activated by both H-RasG12V and H-RasG12V/Y527FSrc membranes, and also a stimulatory, tyrosine phosphoryl-H-RasG12V, could also occur in vitro, c-Raf-1 cytosol was mixed with membranes from COS1 cells expressing ation-related event which occurs only in the presence of H-RasG12V/Y527FSrc membranes. H-RasG12V and Y527FSrc. In the presence of EDTA, the H-RasG12V/Y527FSrc membranes activated c-Raf-1 to the same extent as H-RasG12V membranes alone ( Figure  Active Raf is inactivated by autophosphorylation Although Figures 6-9 demonstrate that tyrosine phos-9C). To measure any potential effect of Y527FSrc on c-Raf-1 activity, the effect of EDTA in preventing phosphorylation of c-Raf-1 is not required for activation by H-RasG12V, there remained the possibility that serine/ phorylation was overcome by the addition of an ATP- threonine phosphorylation is required, as suggested by early studies on c-Raf-1 activation (Blackshear et al., 1990; Morrison et al., 1993) , as well as more recent experiments (Dent et al., 1995a) . As shown in Figure 5 , c-Raf-1 did not become phosphorylated when c-Raf-1 cytosol was mixed with H-RasG12V membranes in the presence of EDTA. However, an activating phosphorylation may have occurred when ATP was added to assay c-Raf-1, as phosphorylation on c-Raf-1 did occur at this stage ( Figure 6A ). This possibility was investigated by preincubating the isolated c-Raf-1/H-RasG12V complex with Mg-ATP, before assaying c-Raf-1 activity, to see the presence of Mg-ATP ( Figure 10B ), or when c-Raf-1 containing acidic mutations at tyrosine residues 340 and This inactivation is substantially reduced when c-Raf-1 activated by H-RasG12V and Y527FSrc is incubated in 341 is incubated in the presence of Mg-ATP ( Figure 10C ). Fig. 9 . Activation of c-Raf-1 by H-RasG12V and Y527FSrc in vitro. c-Raf-1 cytosol was mixed with either H-RasG12V membranes or H-RasG12V/ Y527FSrc membranes, either in the absence or presence of an ATP-regenerating system. Following centrifugation at 100 000 g, c-Raf-1 was immunoprecipitated from the supernatant (unbound) or the pellet (bound), and blotted with phosphotyrosine-specific antibodies (A), the c-Raf-1 C-20 peptide antibody (B), or assayed by activity (C) as described in Materials and methods.
Discussion
ATP, whereas we find that maximal activation by H-RasG12V requires the presence of EDTA to chelate We have established a system for the activation of c-Raf-1 free Mg, and introduction of Mg-ATP in the form of an by H-RasG12V, or by H-RasG12V and Src, in vitro, using ATP-regenerating system actually significantly inhibits the cytoplasmic and membrane extracts from COS1 cells activation. One possible reason for this discrepancy could overexpressing these proteins. An overexpression system be in the use of a mixture of H-RasG12V and Src is not crucial for activation, however, as similar results membranes in the previous studies, compared with just have been obtained using Jurkat T-cell cytosol as an H-RasG12V-expressing cell membranes, or purified endogenous source of c-Raf-1 (our unpublished data). To K-Ras, as used in the present study. We have also been our knowledge, only one other group has reported activunable to activate purified c-Raf-1 isolated from Sf9 cells ation of c-Raf-1 by Ras in vitro (Dent and Sturgill, 1994;  by purified K-Ras or H-RasG12V membranes, either in Dent et al., 1995b) . Using recombinant epitope-tagged the presence or absence of Mg-ATP, and rather have been c-Raf-1 purified from Sf9 cells, and membranes isolated limited to using c-Raf-1 in the presence of crude cytosol. from H-RasG12V-and Src-transformed NIH3T3 cells,
The reason for this is unknown, but it may reflect the they found a significant activation of c-Raf-1, which was requirement of another cytosolic factor, in addition to abolished by pre-incubation of the membranes with an c-Raf-1, for activation. This possibility will be explored N-terminal fragment of c-Raf-1. One significant difference in future work. between our findings and theirs, is in the requirement of The finding that a homogeneous preparation of ATP for activation-they find that activation by H-RasG12V/Src membranes requires the presence of Mg-K-Ras.GTP in the absence of additional membrane com-possible explanation for this apparent discrepancy could be the presence of small amounts of plasma membrane components, even in a 100 000 g supernatant, although if this were the reason, the necessary components would need to be required in extremely non-limiting amounts in the cell. Another possibility is the presence of plasma membrane components in the preparation of processed K-Ras, although this is also unlikely as the preparation is homogeneous by protein staining (our unpublished data), and was washed extensively in the presence of detergent. An alternative explanation could be that recruitment of c-Raf-1 to the plasma membrane may more accurately reflect activation by another mechanism other than by H-RasG12V. This could include tyrosine phosphorylation by a membrane-associated tyrosine kinase (see Marais et al., 1995) , local clustering resulting in c-Raf-1 oligomerization (Farrar et al., 1996; Luo et al., 1996) , or more intriguingly, an interaction of the farnesyl group of RafCAAX mimicking the interaction of the Ras prenyl group, resulting in activation. This latter possibility is supported by recent findings showing a crucial role of the Ras farnesyl group in the interaction with Raf (Hu et al., 1995; Luo et al., 1997) , and an intact zinc finger of Raf was required for this interaction (Luo et al., 1997) . This latter hypothesis is supported by the observation that RafCAAX containing a mutation in the zinc finger is also compromised in its activity (our unpublished data). Experiments involving the isolation of non-farnesylated RafCAAX, followed by farnesylation in vitro should help to resolve the mechanism of activation of RafCAAX, although initial experiments in this laboratory using this approach have proved to be technically difficult. The activation of c-Raf-1 by recombinant processed GTP-loaded K-Ras ( Figure 3B ), and the absolute requirement for post-translational processing, is very reminiscent of the activation of B-Raf that occurs in vitro following addition of processed K-Ras (Itoh et al., 1993; Yamamori et al., 1995) or processed H-Ras (McGeady et al., 1995; Okada et al., 1996) . Interestingly, McGeady and colleagues showed that bacterially expressed H-Ras, which is unable to activate B-Raf, can be converted to a form fully able to activate B-Raf solely by farnesylation, showing that additional Ras processing (carboxy-methylation, proteolysis and palmitoylation) is not required. Ras mutants which are farnesylated, but not palmitoylated, retain the ability to transform cells (Hancock et al., 1990) , albeit at has been demonstrated in Xenopus oocytes, where H-Ras mutants which are farnesylated and methylated, but not ponents is as effective as H-RasG12V membranes in activating c-Raf-1 was initially surprising, as we (Stokoe palmitoylated, are unable to induce meiotic maturation (Dudler and Gelb, 1996). et al., 1994) and others (Leevers et al.) , had previously shown that targeting c-Raf-1 to the plasma membrane was
In experiments to determine whether phosphorylation plays a role in the activation of c-Raf-1 by H-RasG12V, sufficient to cause activation which was independent of H-RasG12V. These experiments suggested the presence we were surprised to find that inclusion of Mg-ATP at two different stages in the protocol had a profound of an additional factor in the plasma membrane which was required for c-Raf-1 activation, and the role of inhibitory effect on c-Raf-1 activity. However, it is currently unclear whether the mechanisms involved are H-RasG12V in this process was to bring c-Raf-1 to this location for activation to take place (Hall, 1994) . One identical. Inclusion of Mg-ATP in the initial mixing step in the presence of cytosol results in an upward mobility N-terminally truncated glycogen synthase kinase-3 was not subject to down-regulation (Wang et al., 1994) . Autoshift on c-Raf-1 ( Figure 9B ) that can be reversed by phosphorylation and inactivation of DNA-dependent protreatment with a bacteriophage serine/threonine-specific tein kinase has also been observed (Chan and Lees-Miller, phosphatase (our unpublished data) . This upward mobility 1996). This phenomenon may reflect a general control shift is similar to that seen upon prolonged growth factor mechanism whereby a protein kinase remains active while stimulation (Traverse and Cohen, 1994) , or upon activation there is substrate present, but upon depletion of substrate of kinases downstream of Raf (Samuals et al., 1993) . A or relocation to a different location in the cell, it can turn potential negative regulatory role for this phosphorylation off its activity. Evidence for phosphorylation playing a has been suggested by experiments utilizing a compound role in Raf inactivation has also been suggested from that inhibits the activation of MEK, PD98059 (Alessi studies in the eye development pathway in Drosophila. Dudley et al., 1995) . Stimulation of Swiss3T3 this system, a mutant of the catalytic subunit of Drosophila cells with PDGF (Alessi et al., 1995) , or Rat1 cells with PP2A was shown to suppress the rough eye phenotype EGF (our unpublished data), causes a transient activation induced by an activated Raf allele. Moreover, the same of c-Raf-1, which is rapidly reduced to baseline levels mutation in PP2A enhances the phenotype induced by a within 30 minutes, concomitant with an upward mobility mutation in Raf which causes a lower level of wild-type shift. Prior incubation of PD98059 in the culture medium Raf transcription (Wassarman et al., 1996) . Taken together, abolishes the mobility shift of c-Raf-1, and prolongs the these results suggest that dephosphorylation of Raf, at least activity to several hours (Alessi et al., 1995, and our in Drosophila, can be associated with positive regulation of unpublished data). Although these data may indicate a Raf activity. One caveat regarding inactivation of c-Raf-1 role for the hyperphosphorylation of c-Raf-1 in negatively following incubation with Mg-ATP, is that its activity regulating its activity, and indicate a kinase downstream could not be restored by treatment with a serine/threonineof Raf, an alternative explanation may lie in the ability specific phosphatase (our unpublished data). Whether this of ERK to phosphorylate and down-regulate Sos, thereby reflects an irreversible inhibition of c-Raf-1, or whether reducing GTP levels on Ras (Porfiri et al., 1996) . The the phosphatase is removing additional phosphates possibility that ERK is involved in Raf phosphorylation required for activity remains to be determined. and down-regulation was explored more directly by There has been much confusion regarding the mechaninhibiting the ability of ERK to phosphorylate c-Raf-1 ism of activation of c-Raf-1, and most, if not all, recent in vitro. The inclusion of kinase-dead MEK, or a synthetic published results suggest a role for phosphorylation in the inhibitor of ERK, caused a reduction in the c-Raf-1 band activation of c-Raf-1, both on tyrosine residues (Fabian shift, and slightly restored the ability of c-Raf-1 to become et al., 1993; Dent et al., 1995a; Jelinek et al., 1996) , and activated by H-RasG12V membranes in the presence of on serine/threonine residues (Kolch et al., 1993 ; Dent Mg-ATP (our unpublished data). However, this restoration et al., 1996) . Our results using an in vitro system to was relatively minor, and PD98059 had no effect on study the mechanism of c-Raf-1 activation in detail, have restoring c-Raf-1 activation (our unpublished data), sugprovided strong evidence that activation by Ras can occur gesting that additional mechanisms were preventing in the absence of phosphorylation, and is most likely c-Raf-1 activation in the presence of Mg-ATP, for example, through a conformational change mediated by direct the autophosphorylation and inactivation of purified Raf binding of the farnesyl group of Ras to c-Raf-1, perhaps ( Figure 10 , also discussed below).
to the cysteine-rich moiety, as suggested in Luo et al. Addition of Mg-ATP to c-Raf-1 following affinity (1997) . Phosphorylation in these experiments is accompurification results in a rapid inactivation of c-Raf-1 panied by a rapid inactivation of c-Raf-1 activity. The ( Figure 10A ) which, under these circumstances, is not sites of phosphorylation occurring under different circumaccompanied by an upward mobility shift in the majority stances are currently being investigated. In contrast, the of the c-Raf-1 protein (our unpublished data). This may activation by Src in vitro requires Mg-ATP and is accomreflect autophosphorylation of c-Raf-1, or phosphorylation panied by tyrosine phosphorylation, consistent with preby a contaminating kinase in the immune complex. The vious observations on the role of Src in c-Raf-1 activation. latter possibility seems less likely, as only c- To what extent these different mechanisms controlling incorporates 32 P-phosphate under these conditions (Figure c-Raf-1 activity occur in vivo under different conditions 6A). Also, addition of a specific peptide inhibitor of remains to be elucidated. The question of which mechanprotein kinase A to the incubation, or a synthetic inhibitor ism is most important in the initiation and maintenance of the transformed phenotype is clearly much more difficult of ERK, had no effect on the inactivation of c-Raf-1 (our to resolve, though will be of the most importance theraunpublished data), excluding the possibility of contaminpeutically. Optimistically, one could suggest that, the more ation of the c-Raf-1 immune complexes by either of these ways that c-Raf-1 can be shown to be activated, the more kinases. Autophosphorylation and inactivation of Raf has potential ways there are to inhibit its activity in tumor also been noted by other investigators (Mischak et al., cells. Hence, compounds which inhibit oligomerization, 1996) , and autophosphorylation and inactivation of at tyrosine phosphorylation, or interaction of c-Raf-1 with least two other protein kinases has also been previously Ras farnesyl group, could all be considered as potential described. Wang and co-workers (1994) showed that prior therapies. incubation of glycogen synthase kinase-3α or β with Mg-ATP, caused a marked inactivation against a peptide
Materials and methods
substrate. This was probably due to phosphorylation on Ser9, a residue previously implicated in the down-regulaCell culture and fractionation tion of glycogen synthase kinase-3 activity (Sutherland COS1 cells were cultured in 25ϫ15 cm flasks containing 30 ml Dulbecco's Modified Eagle's Medium supplemented with 100 U/ml Cross et al., 1995) , as incubation of penicillin, 100 μg/ml streptomycin and 2 mM glutamine in the presence were added to the cytosolic and membrane fractions immediately before mixing. of 10% Donor Calf Serum in a humidified atmosphere with 10% CO 2 at 37°C. When the cells reached 80-90% confluency, they were trypsinized from the flask, washed with HEBS buffer (20 mM HEPES, Immunoprecipitation and immunoblotting Epitope-(myc or glu-glu) tagged full-length c-Raf-1 was immunoprecipitpH 7.05, 137 mM NaCl, 5 mM KCl, 0.7 mM Na 2 HPO 4 , 6 mM glucose) and resuspended at 12ϫ10 6 cells/ml in HEBS buffer. cDNAs of interest ated using either protein G-Sepharose pre-conjugated with the monoclonal myc antibody 9E10 (Evan et al., 1985) or a glu-glu monoclonal (10 μg each), cloned into the expression vector pEXV, were transfected into 3ϫ10 6 cells by electroporation in the presence of 100 μg salmon antibody (Grussenmeyer et al., 1985) , or with 10 μg of a polyclonal C-12 peptide c-Raf-1 antibody (Santa Cruz Biotechnology, Santa Cruz, sperm DNA as carrier. Cells and DNA were placed in a 0.4 cm electroporation cuvette (Bio-Rad) and pulsed with 250 V/125 mF giving California), followed by addition of protein A-Sepharose beads. Incubation was at 4°C for 1 h on a rotating platform. The beads were collected a time constant of 5-6 ms. Following electroporation, cells were seeded onto 10 cm dishes containing 10 ml of serum-containing medium for by centrifugation at 13 000 g for 1 min, and washed twice with 1 ml ice-cold wash buffer (20 mM Tris-HCl, pH 7.5, 137 mM NaCl, 1 mM 48 h, then switched to serum-free medium 18 h before harvesting. Cells were washed once with phosphate-buffered saline, before scraping into EGTA, 1.5 mM MgCl 2 , 1% Triton X-100, 10% glycerol, 1 mM DTT, 1 mM NaVn). The beads were drained of wash buffer using a Hamilton 0.4 ml/dish hypotonic lysis buffer (HLB: 10 mM Tris-HCl, 1 mM EDTA, 25 mM NaF, 1 mM NaVn, 1 mM DTT, 10 μg/ml aprotinin, syringe, and resuspended in 30 μl kinase buffer (20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 75 mM NaCl, 1 mM DTT, 1 mM NaVn). Two 10 μg /ml soybean trypsin inhibitor, 10 μg /ml leupeptin and 1 mM pefabloc). The cells were lysed by 30 strokes in a Dounce homogenizer, 5 μl aliquots of this immunoprecipitate were used for a duplicate kinase assay, and the remaining 20 μl was resolved by SDS-PAGE on 1.5 mm subjected to centrifugation at 1500 g to pellet nuclei and unbroken cells, followed by centrifugation of the supernatant at 100 000 g for 20 min. gels (Novex, San Diego, CA) and transferred electrophoretically to a poly(vinylidene difluoride) membrane (Millipore, Bedford, MA) at The supernatant (~400 μl) was collected (S100 fraction) and the pellet resuspended in 100 μl HLB (P100 fraction). Throughout the manuscript, 80 mA/gel for 1 h in a semi-dry blotting apparatus (Pharmacia, Uppsala, Sweden). The blots were blocked for 1 h in phosphate-buffered saline the terms cytosol and membranes have been substituted for S100 and P100.
containing 0.1% Tween-20 (PBST) and 5% dried milk (Marvel), washed 3ϫ5 min with PBST, then incubated for 1 h with blocking solution When K-Ras was added to control membranes, the membranes were further purified by centrifugation through a sucrose gradient containing containing a polyclonal C-20 peptide c-Raf-1 antibody (Santa Cruz Biotechnology, Santa Cruz, California) at 1:3000 (for c-Raf-1) or the rat 1 mM NaVn, 1 mM DTT, 10 μg/ml aprotinin, 10 μg/ml soybean trypsin inhibitor, 10 μg/ml leupeptin and 1 mM pefabloc. 400 μl of a 15% monoclonal antibody Y13-259 at 1:2000 (for Ras). The primary antibody was removed and the blots washed 3ϫ5 min with PBST, before (w/v) sucrose solution was carefully layered on top of 400 μl of a 45% (w/v) sucrose solution in a 11ϫ34 mm polycarbonate centrifuge tube incubation with the appropriate goat secondary antibody coupled to horseradish peroxidase (Bio-Rad, Hercules, California) diluted 1:10 000 (Beckman). 50 μl of control membranes were then carefully layered on top of this, and the tube centrifuged at 54 000 r.p.m. in a TLS 55 swing in blocking buffer for 1 h. The blots were then washed 3ϫ5 min with PBST and immunoreactive proteins visualized by enhanced chemiluminout rotor (Beckman) for 30 min at 4°C. Membranes were collected from the 15%/45% interface, unless the membranes were stripped of proteins, escence. When antiphosphotyrosine antibodies 4G10 and PY20 (UBI, Lake Placid, New York) were used as primary antibodies, the procedure in which case they were collected at the 0%/15% interface. The membranes were washed once in 500 μl HLB, repelleted at 100 000 g, was identical, except that the milk in the blocking solutions was replaced by 2% BSA. The blots were stripped of antibodies by incubating in a and resuspended in 50 μl HLB. solution containing 62.5 mM Tris-HCl, pH 6.8, 2% SDS and 100 mM 2-mercaptoethanol at 55°C for 30 min with occasional shaking, replacing Purification of epitope-tagged proteins from Sf9 cells the buffer once during the incubation, as described by the manufacturer Processed and unprocessed epitope-(EYMPME, referred to as Glu-Glu) (Millipore, Bedford, MA). tagged K-Ras proteins were purified from the aqueous and detergent phases of Sf9 cells expressing K-Ras(4B) as previously described (Porfiri Assay of Raf activity et al., 1995) , with the substitution of 0.5% (w/v) sodium cholate with 5 μl of c-Raf-1 immunoprecipitate was added to 15 μl of kinase buffer 1.2% (w/v) n-octyl-β-D-glucopyranoside in the buffers used to purify containing 2 μg of purified GST-ERK1 and 0.5 μg of purified glu-gluprocessed K-Ras. Glu-Glu-tagged MEK1 proteins were purified from tagged MEK1. The reaction was initiated by the addition of 5 μl of a Sf9 cells, and GST-ERK1 was purified from Escherichia coli, essentially solution containing 50 mM MgCl 2 and 500 μM ATP, and was placed in as previously described (MacDonald et al., 1993) . a shaking heater block maintained at 30°C. After 30 min (for the standard assay), a 2 μl aliquot was removed and diluted into 40 μl ice-cold kinase Preparation of unilamellar phospholipid vesicles buffer containing 16 μg myelin basic protein. 10 μl of a solution 10 nmol each of phosphatidylethanolamine (PE), phosphatidylserine containing 50 mM MgCl 2 , 500 μM ATP and 2.5 μCi [γ-32 P]ATP, was (PS), phosphatidylinositol (PI), and 5 nmol phosphatidylcholine (PC) then added to start the reaction. After 10 min at 30°C, a 40 μl aliquot were dried down under nitrogen in a glass vial, and resuspended in was removed and spotted onto a 2ϫ2 cm square of phosphocellulose 100 μl HLB by three consecutive treatments of alternate bath sonication P81 paper (Whatman, Maidstone, UK). The papers were washed four and vortexing (15 s each).
times in 400 ml 75 mM phosphoric acid, rinsed once in acetone, dried, and the incorporated 32 P-phosphate measured in a scintillation counter in the presence of liquid scintillant. c-Raf-1 activity is expressed in In vitro activation of Raf by Ras, or Ras and Src 200 μl cytosol from epitope-(myc or glu-glu) tagged c-Raf-1-transfected Units as previously defined (Alessi et al., 1994) , and was diluted to a concentration that was on the linear scale, as determined by assaying at COS1 cells was mixed with 50 μl membranes from H-RasG12V-transfected COS1 cells, or 50 μl membranes from COS1 cells transfected 15 min in addition to 30 min. c-Raf-1 activity stated in the graphs is that which was recovered from one dish of transfected COS1 cells, and with H-RasG12V and Y527FSrc, for 10 min at ambient temperature on a rotating platform, followed by centrifugation at 100 000 g for 20 min.
the immune complex resuspended in 30 μl of kinase buffer. The data shown are the average of duplicate points from one experiment. Each The supernatant was removed, adjusted to 1% NP-40, and c-Raf-1 was immunoprecipitated as described below. The pellet was resuspended in experiment shown was performed at least three times with similar results. 100 μl HLB containing 1% NP-40, vortexed, left on ice for 10 min, vortexed again, and centrifuged at 13 000 g for 5 min to remove Phosphoamino acid analysis 20 μl of the Ras Y13-238 immunoprecipitate was incubated for 30 min insoluble material. c-Raf-1 was immunoprecipitated from the supernatant as described below. When recombinant K-Ras was added to c-Raf-1 at 30°C in the presence of 10 mM MgCl 2 , 100 μM ATP and 2.5 μCi [γ-32 P]ATP. The beads were washed three times in ice-cold wash buffer, cytosol, 1 μg processed or unprocessed K-Ras was loaded with 5 mM GTPγS or GDPβS in the presence of 2 mM EDTA in a volume of 10 μl, and then hydrolyzed in 50 μl 6 M HCl at 100°C for 2 h. Following centrifugation at 13 000 g for 5 min, the supernatant was collected, for 10 min at ambient temperature. This was then either added to 50 μl control membranes, or 50 μl phospholipid vesicles for 10 min on dried under vacuum, and dissolved in 2 μl pH 1.9 electrophoresis buffer [formic acid (88%):acetic acid:water, 50:156:1794 (v/v)]. Phosphoamino ice, followed by re-purification of the membranes or vesicles on sucrose gradients.
acids were resolved on a thin-layer cellulose plate in two dimensions as previously described (Cooper et al., 1983) . Standards were visualized In indicated experiments ATP was added to the incubation in the form of an ATP-regenerating system: 10 mM creatine phosphate, 5 mM by staining with 0.2% ninhydrin in acetone and 32 P-labeled residues were detected by autoradiography overnight. MgCl 2 , 2 mM ATP, and 50 μg/ml creatine kinase (final concentrations)
